# A Pilot of Methylphenidate in Mild Cognitive Impairment and Dementia Participants.

> **NCT03811847** · PHASE4 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 11 (actual)

## Conditions studied

- Alzheimer Dementia

## Interventions

- **DRUG:** Methylphenidate Extended Release Oral Capsule
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03811847
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-01
- **Primary completion:** 2021-08-30
- **Final completion:** 2021-08-30
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2023-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03811847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03811847, "A Pilot of Methylphenidate in Mild Cognitive Impairment and Dementia Participants.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03811847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*